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As diverse pruritic cutaneous diseases respond to ultra-
violet treatment, we have examined whether ultraviolet
light is capable of inducing apoptosis in mast cells. Hu-
man mast cell line 1 (HMC1) derived from a patient
with malignant mastocytosis and puri¢ed skin mast
cells were irradiated with single doses of ultraviolet B
or ultraviolet A1, or pretreated with 8-methoxypsoralen
prior to ultraviolet A1 exposure. After 0 to 48 h of incu-
bation, the percentage of apoptotic and dead cells was
assessed. In HMC1 cells, morphologic features of apop-
tosis were further evaluated by electron microscopy. All
ultraviolet treatment induced apoptosis of HMC1 cells
in a time- and dose-dependent manner. Apoptosis was
associated with activation of caspase-3, release of cyto-
chrome C, cleavage of poly(ADP-ribose)-polymerase,
and nuclear accumulation of p53. In contrast, resting
skin mast cells were resistant to ultraviolet light in-
duced apoptosis. After incubation with stem cell factor
and interleukin-4 for 2 wk, however, slowly proliferat-
ing skin mast cells also underwent apoptosis in response
to ultraviolet light. In conclusion, these data demon-
strate that ultraviolet light directly a¡ects mast cells,
but mainly aims at the proliferating mast cells as found
in mastocytosis and mast cell dependent pruritic dis-
eases, where increased numbers are observed due to
the recruitment mast cell precursors from the blood.
Key words: apoptosis/human/mast cells/skin. J Invest Derma-
tol 121:837 ^844, 2003
U
ltraviolet (UV) irradiation is a well established
treatment for a great variety of in£ammatory dis-
eases (Horio, 2000). The e⁄cacy of this therapy is
primarily attributed to its diverse immunomodu-
latory e¡ects (Duthie et al, 1999). In human and
murine mast cells, UV irradiation has been found to induce de-
granulation at higher doses, whereas exposure to lower doses in-
hibited the codeine phosphate- or calcium ionophore-mediated
histamine release both in vitro and in vivo (Gollhausen et al, 1985;
Kr˛nauer et al, 2001). Treatment with UV light has also been
shown to cause a 50% decrease of dermal mast cells in rats (Val-
tonen et al, 1964). In addition, a decrease of mast cells has been
observed in patients with atopic dermatitis and cutaneous masto-
cytosis following UV treatment especially in the upper dermis
where UV light would be most e¡ective (Kolde et al, 1984;
Grabbe et al, 1996). As UV irradiation represents one of the most
powerful natural stimuli of apoptosis in diverse cell types within
the skin, including keratinocytes, lymphocytes, and Langerhans
cells (Rattis et al, 1998; Petit-Frere et al, 2000a), it is well conceiva-
ble that mast cells are also eliminated by UV-induced apoptosis.
The e¡ect of UV light on apoptosis of human mast cells, how-
ever, has not been studied so far.
Apoptosis allows for the selective elimination of individual
cells with irreparable DNA damage, as best exempli¢ed by the
so-called sunburn cells that arise after intense UV irradiation in
the epidermis (Schwarz et al, 1995). Morphologically, apoptotic
cells are characterized by typical features such as cell shrinkage,
membrane blebbing, fragmentation of nuclear chromatin, and
the formation of apoptotic bodies. An in£ammatory response in
the immediate surrounding of the cells is usually lacking (Paus et
al, 1993). Besides UV irradiation, several other mechanisms are
known to induce apoptosis such as deprivation of growth factors,
stimulation of death receptors, and bacterial toxins (Owen-
Schaub et al, 1992; Carceres-Cortes et al, 1994; Iwai et al, 1994). Ex-
ecution of the intracellular apoptotic program induced by these
mechanisms involves a variety of complex biochemical pathways
(Evan and Littlewood, 1998; Godar, 1999a). One molecule of cri-
tical importance in the control of apoptosis is the tumor suppres-
sor p53 (Miyashita and Reed, 1995; Lin et al, 2000; Oda et al,
2000a,b), which activation is also involved in cell cycling, di¡er-
entiation, transcription, and DNA repair. In UV-induced apopto-
sis of keratinocytes, p53 has been shown to participate in both
induction of apoptosis as well as repair of UV-damaged DNA.
Apart from p53 activation, execution of apoptosis is also asso-
ciated with changes of the mitochondrial membrane permeabil-
ity, resulting in the formation of ‘‘megapores’’ followed by the
release of cytochrome C into the cytosol (Kluck et al, 1997).
Cytosolic cytochrome C subsequently activates a series of pro-
teases, most importantly caspases (cytosolic aspartate speci¢c cy-
steine proteases) (Tada-Oikawa et al, 1998). The group of caspases
is ¢nally responsible for the disassembly of the cell into apoptotic
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bodies (Cohen, 1997). Caspase-8 and caspase-9 activate caspase-3
by proteolytic cleavage and caspase-3 then cleaves other vital in-
tracellular proteins such as poly (ADP-ribose) polymerase
(PARP). Cleavage of PARP into two inactive fragments of 85
and 25 kDa (Yu et al, 2001), resulting in functional loss of the en-
zyme has deleterious e¡ects as this molecule is normally essential
for the surveillance of genotoxic stress, telomere replication, and
cellular transport (Smith, 2001).
In contrast to other cell types, studies investigating the me-
chanisms that regulate apoptosis in human mast cells are limited.
Murine mast cells have been reported to undergo apoptosis in re-
sponse to activation of CD95 and deprivation of growth factors
such as interleukin (IL)-3 and stem cell factor (SCF) (Mekori et al,
1993; Yee et al, 1994; Hartmann et al, 1997), whereas monomeric
IgE has recently been shown to prevent apoptosis of cytokine-de-
prived murine mast cells (Asai et al, 2001; Kalesniko¡ et al, 2001).
Survival of di¡erent human mast cell systems has been found to
depend upon SCF, IL-6, IL-4, and adhesion to endothelial cells
(Oskeritzian et al, 1999; Mierke et al, 2000; Kambe et al, 2001).
Apoptosis of human mast cells derived from peripheral blood
CD34-positive progenitor cells in response to deprivation of the
growth factor SCF has been linked to a downregulation
of the anti-apoptotic molecules Bcl-2 and Bcl-XL (Mekori et al,
2001).
In rat basophil leukemia cells, A3 adenosine receptor agonists
have been used to study modulation of UV light induced apop-
tosis (Gao et al, 2001) and Szepietowski et al (2002) were able to
demonstrate apoptosis in response to broad and narrow band
UVB light in the murine mastocytoma cell line P815. In order
to examine whether human mast cells undergo apoptosis in re-
sponse to UV light, we have studied the survival in response to
di¡erent types and intensities of UV light of puri¢ed mature cu-
taneous mast cells as well as the e¡ects on the human leukemic
mast cell line HMC-1, which has been described as a human im-
mature and proliferating mast cell.
MATERIALS AND METHODS
Cells and cell culture The human leukemic mast cell line HMC-1was
kindly provided by Dr J.H. Butter¢eld, Mayo Clinic, Rochester,
Minnesota (Butter¢eld et al, 1988). HMC-1 cells were kept routinely at
5% CO2 and 371C in basal Iscove’s containing 10% heat inactivated fetal
calf serum, 4 mM L-glutamine, 100 U per mL penicillin, and 100 mg
streptomycin per mL (all from Biochrom, Berlin, Germany), and 0.002%
a-monothioglycerol (Sigma, Deisenhofen, Germany). The human
leukemic, basophilic cell line KU812 and HaCaT cells were cultured in
RPMI 1640 containing 10% heat inactivated fetal calf serum, 4 mM L-
glutamine, 100 U per mL penicillin, and 100 mg streptomycin per mL (all
from Biochrom).
Highly puri¢ed dermal mast cells were isolated from breast skin excised
for cosmetic reasons after informed consent, as previously described
(Grˇtzkau et al, 2000). This study has been approved by the ethical
committee of the charite. Brie£y, after enzymatic and mechanical removal
of the epidermis and enzymatic digestion of minced dermal tissue, mast
cells were isolated from the cell suspension by sorting with the anti-
CD117 (c-Kit) monoclonal antibody YB5.B8 (kindly provided by Dr L.
Ashman, Adelaide, Australia) and goat anti-mouse magnetic beads
(Miltenyi Biotec, Bergisch-Gladbach, Germany). Mean ¢nal purity was
always greater than 90%, as shown by acidic toluidine blue staining
and £ow cytometry with an anti-CD117 antibody (Dianova, Hamburg,
Germany) that binds to a di¡erent epitope than that recognized by
YB5.B8. For up to 2 d, puri¢ed mast cells were maintained in HMC-1
medium. For experiments lasting up to 2 wk media were supplemented
either with SCF at 50 ng per mL and IL-4 at 5 ng per mL to support
survival (repetitive irradiation experiments), or referring to the model of
Bischo¡ (Bischo¡ et al, 1999) supplemented with SCF at 100 ng per mL
and IL-4 at 20 ng per mL to induce proliferation (both from TEBU,
Frankfurt a.M., Germany).
Freshly isolated keratinocytes were obtained from epidermal sheets
removed for mast cell puri¢cation by trypsin/ethylenediamine tetraacetic
acid (0.025%/0.002%) treatment. Evaluation of keratinocyte viability was
performed using trypan blue staining. Viability was always greater than
90%. Keratinocytes were kept in KBM Medium (Clonetics, San Diego,
California) supplemented with bovine pituitary extract, human epider-
mal growth factor, insulin, hydrocortisone, transferrin, epinephrine, and
GA-1000.
UV irradiation For UVB irradiation, aWaldmann UV800 light source
was used (Waldmann,VS Schwenningen, Germany).The UVA1 source was
constructed by the hospital technical service.Table I shows the distribution
of power inW per m2 for the di¡erent wavelength ranges of both sources.
Prior to irradiation, the cell cycle of the proliferating HMC-1 cells was
synchronized for 24 h in basal Iscove’s medium containing 1% bovine
serum albumin (Sigma). Skin mast cells were used immediately after
puri¢cation. During exposure to UV light cells were kept in uncovered
Petri dishes. HMC-1 cells were irradiated with UVB doses of 5, 25, 50, 75,
and 100 mJ per cm2 applied over 6 s to 2 min and UVA1 doses of 5, 10, 15,
20, and 25 J per cm2 applied over 12 min to 1 h. For psoralen plus UVA1
(PUVA1) treatment, cells were preincubated for 30 min in 500 ng 8-
methoxypsoralen (8-MOP) per mL (Galderma, Freiburg, Germany) and
subsequently irradiated with UVA1 doses of 1, 2, 3, 4, and 5 J per cm2
applied over 2 to 12 min. As dermal mast cells were not available in large
numbers, they were treated according to the same protocol using only one
or two doses found e¡ective with HMC-1 cells (75 and 100 mJ per cm2
UVB, 15 J per cm2 UVA1, and 5 J per cm2 PUVA1). Additional
experiments included increasingly higher doses of UVB (up to 500 mJ
per cm2) or repetitive dosing approximating conditions during in vivo
treatment (UVB, 5 mJ per cm2, 3 per wk 2 wk). For control, cells
were kept in the dark for the respective irradiation times (sham). After
irradiation, cells were kept in medium for times indicated, and analyzed
for biologic e¡ects.
Apoptosis induction by staurosporine and cycloheximide and UVB
in di¡erent cell types In order to determine the general response to
apoptotic stimuli, dermal mast cells, slowly proliferating mast cells
(cultured for 2 wk in medium supplemented with SCF 100 ng per mL
and IL-4 20 ng per mL) and highly proliferating leukemic mast cells
(HMC-1), as well as freshly isolated keratinocytes, immortalized
keratinocytes (HaCaT) and the leukemic basophil cell line KU812 were
treated with staurosporine, cycloheximide, and single dosage of UVB
light. All cells and cell lines were treated with staurosporine (10 mM),
cycloheximide (10 mg per mL), and UVB 100 mJ per cm2 and harvested
24 h after treatment for the determination of caspase-3 activation, but
referring to the rapid onset and severity of apoptosis, KU812 were treated
with staurosporine at 1 mM, cycloheximide at 10 mg per mL and UVB at
20 mJ per cm2 and harvested 8 h after treatment.
Assessment of cell death and apoptosis To assess apoptosis and cell
death the Vybrant Apoptosis Assay Kit no. 4 (Molecular Probes, Leiden,
the Netherlands) was used. The principle of this assay is based on the
di¡erent uptake of the two nuclear dyes YO-PRO-1 and propidium
iodide by viable, apoptotic, and dead cells. The intact membrane of viable
cells is capable of excluding both dyes, whereas changes in the permeability
of the cytosolic membrane, occurring during apoptosis, allowsYO-PRO-1
to enter the cell, whereas propidium iodide is still excluded. In case of dead
cells both dyes penetrate the membrane. On £ow cytometric analysis, this
double staining assay allows to distinguish dead cells by their green/red
double £uorescence from apoptotic cells with only green, and viable cells
with no £uorescence. For £ow cytometry, 5105 HMC-1 or 0.5 to 1105
mature mast cells were stained for di¡erent time intervals, and 5103
to 1104 cells were analyzed with a £ow cytometer (Coulter, Krefeld,
Germany) using Xl2 software. Results are expressed in percentage of
dead, apoptotic, or viable cells.
Transmission electron microscopy For assessment of ultrastructural
signs of apoptosis, 1107 cells were ¢xed for 6 or 12 h after irradiation in
Karnovsky’s ¢xative, as described (Weber et al, 1996). Semithin sections (0.5
mM) were mounted on glass slides and stained with toluidine blue for rapid
Table I. Power of UV sources at di¡erent UV ranges
UVB source UVA1 source
(W per m2) (W per m2)
UVC (100^280 nm) 0.051 3.210-6
UVB (280^315 nm) 7.580 0.006
UVA (315^400 nm) 6.918 53.80
UVA1 (340^400 nm) 1.734 53.78
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preliminary evaluation. Ultrathin sections (50 nm) were stained with
uranyl acetate and lead citrate. Specimens were examined with an
80 kV Zeiss EM10 transmission electron microscope (Zeiss, Oberkochen,
Germany).
Measurement of caspase-3 activity For assessment of caspase-3
activity, UV-irradiated, staurosporine or cycloheximide treated, or control
cells were harvested at di¡erent time intervals after treatment, washed
twice in PBS, and lyzed at 1106 cells per 50 mL. Samples were
centrifuged, and 50 mL of the supernatant from each sample were
analyzed in duplicates (KU812, HaCaT, and freshly isolated keratinocytes)
or triplicates (HMC-1), or in case of dermal mast cells due to the limit-
ing cell number as a single determination using 96 well £uorescence
microplates. Caspase-3 activation was determined by the cleavage of the
Z-DEVD-AMC substrate using the EnzCheck Caspase-3 Assay kit
(Molecular Probes). Results are expressed as OD units resulting from the
7-amino-4-methylcoumarin liberation of 1106 cells over 2 h at 251C.
Preparation of nuclear extracts and western blotting At di¡erent
time intervals after irradiation, 2.5107 cells were harvested from culture
£asks, and washed two times with PBS without Ca2þ , Mg2þ . The pellet
was resuspended in 1000 mL cell lysis bu¡er (50 mM Tris, 1% Triton X100,
150 mM NaCl, pH 8, 5 mg per mL aprotinin, 5 mg per mL leupeptin, 100
mg per mL phenylmethyl-sulfonyl £uoride) and kept on ice for 30 min
then centrifuged 20 min at 20,000 g. The remaining pellet was treated
with 500 mL of nuclear extraction bu¡er (10 mM HEPES, 25% glycerol,
5 mM MgCl2, 0.1 mM CaCl2, 0.1 mM ethylenediamine tetraacetic acid,
01 mM ethyleneglycol-bis-(b-aminoethylether)-N,N,N0,N0-tetraacetic acid,
500 mM NaCl, 10 mM NaF, 0.5 mM spermidine, 0.15 mM spermine, 7
mM mercaptoethanol, 1 mM levamisole, and protease inhibitors as
described in cell lysis bu¡er) for 30 min on ice and then centrifuged for
20 min at 20,000 g. Total protein content was determined using the
Coomassie plus protein assay reagent kit (Pierce, Perbio Science, Bonn,
Germany). Equal amounts of nuclear extracts (20 mg per lane) were
separated by discontinuous SDS^PAGE using a 10% separating and a 5%
stacking gel and subsequently proteins were blotted on to a polyvinylidene
di£uoride transfer membrane using a semidry transfer cell. After blocking
(1 h, 6% nonfat dry milk) the membrane was immunoprobed overnight at
41C with 0.25 mg per mL of the monoclonal mouse anti-human p53
antibody (clone DO7, Becton Dickinson, Heidelberg, Germany) or with
0.5 mg per mL of the polyclonal rabbit anti-human PARP antibody (Santa
Cruz, Heidelberg, Germany). After a 1 to 2 h incubation at room tem-
perature with goat anti-mouse antibody coupled to horseradish peroxidase
(1:5000 dilution; Chemicon International, Hofheim/Ts, Germany) or an
equally coupled goat anti-rabbit antibody (1:2500 dilution, DAKO,
Hamburg, Germany), nuclear proteins were visualized using the ECL
(enhanced chemiluminescence) plus western blotting detection system
(Amersham Pharmacia Biotech, Uppsala, Sweden).
Assessment of mitochondrial transmembrane depolarization
Alterations in membrane potential of mitochondria (c) were visualized
by £ow cytometry with the cationic dye 5,50,6,60 -tetrachloro-1,10,3,30 -
tetraethyl benzimidazolyl carbocyanine iodide (JC-1) (Molecular Probes),
as described (Bossy-Wetzel et al, 1998). The color of this dye depends only
on the membrane potential and shifts from a green/red double signal
(intact c) to green £uorescence in case of depolarization. For each
experiment, 5105 cells were labeled for 10 min with JC-1 at 10 mg per
mL, washed and then analyzed by £ow cytometry.
Preparation of cytosolic extracts and cytochrome C release To
evaluate the release of cytochrome C from mitochondria, 1106 cells
were harvested at di¡erent times from culture £asks, washed twice in
cold PBS, resuspended in 1 mL extraction bu¡er (50 mM PIPES-KPH
bu¡er pH 7.4 containing 200 mM mannitol, 68 mM sucrose, 5 mM
ethyleneglycol-bis-(b-aminoethylether)-N,N,N0,N0-tetraacetic acid, 2 mM
MgCl2, 1 mM dithiothreitol, and a protease inhibitor cocktail
(Boehringer, Mannheim, Germany), kept for 30 min on ice, and then
homogenized on ice with 40 strokes, using a Wheaton potter (Wheaton,
New Jersey). Homogenisates were centrifuged at 14,000 g, and
supernatants were shock frozen in liquid nitrogen and stored at ^801C
until analysis. Evaluation of cytochrome C was done using a commercial
enzyme-linked immunosorbent assay (R&D Systems,Wiesbaden, Germany),
according to the instructions of the manufacturer.
RESULTS
UV irradiation induces apoptosis of HMC-1 cells In HMC-1
cells, a time- and dose-dependent apoptotic response was observed
after irradiation with UVB, UVA1, and PUVA1. With all three
types of treatment, the onset of apoptosis occurred already 6 h
after the irradiation and maximal levels of apoptotic cells were
reached after 12 and 24 h. At this time about 40 to 50% of the
cells challenged with UVB doses of 50 to 100 mJ per cm2 were
apoptotic. The threshold dosage for the induction of apoptosis
after UVB treatment is about 25 mJ per cm2 (Fig 1A). In case of
UVA110 to 15 J per cm2 are necessary to cause signi¢cant amounts
of apoptosis. Maximal levels of 34% apoptotic cells were reached
at 12 h post-UVA1 (20 J per cm2) irradiation (Fig 1B). Pretreatment
with photo-sensitizer 8-MOP was able to enhance UVA1-induced
apoptosis (Fig 1C), especially when low doses of UVA were
applied, which by themselves were insu⁄cient to trigger an
apoptotic response. The lowest dose of PUVA1 irradiation (1 J per
cm2), for example, was su⁄cient to induce marked apoptosis after
only 12 h. Incubation with 8-MOP alone had no direct apoptotic
or toxic e¡ects on HMC-1 cells, as evident from the values of
nonirradiated control cells (Figs 1C and 2C). In the ¢rst 12 to
24 h, whereas the maximum of apoptotic cells is reached, the
number of dead cells remain nearly una¡ected (Fig 2A^C).
Slightly elevated levels of dead cells (9^14%) in comparison with
control (4%) can only be seen at UVA1doses of 20 to 25 J per cm2
(Fig 2B). Later when apoptosis rates decline, however, the death of
cells becomes evident with levels up to 80 or 90%. This time
course indicates that the cell death is a result of the apoptotic
process and not primarily a matter of a necrotic pathway. Typical
apoptotic features of HMC-1 cells treated with UVB irradiation
were also revealed by electron microscopic examination (Fig 3).
Compared with nonirradiated control cells (Fig 3A), morpho-
logic features of apoptosis such as cell shrinkage, membrane
blebbing, nuclear chromatin condensation, and formation of
apoptotic bodies were observed as exempli¢ed by cells 12 h after
irradiation with UVB (Fig 3B).
Caspase-3, p53, PARP cleavage, and cytochrome C are
involved in UV irradiation-induced apoptosis of HMC-1
cells To investigate further the mechanisms involved in UV
irradiation mediated apoptosis of HMC-1 cells, several
intracellular, biochemical steps that have been described to
participate in UV irradiation-induced apoptosis in other cell
types were examined. After all three types of UV treatment, an
enhanced activity of e¡ector caspase-3, which represents one of
the main enzymes involved in the process of apoptosis, was
detected by measurement of DEVD-AMC cleavage (Fig 4A^C),
with a time and dose^response closely paralleling that of the
apoptosis assay (Fig 1A^C). Furthermore, a pronounced induc-
tion and nuclear accumulation of p53 protein was observed in
HMC-1 cells treated with UVB (Fig 5A), UVA1 (Fig 5B), as
well as PUVA1 (Fig 5C). Enhanced expression was ¢rst
detectable at 4 to 8 h after irradiation in all settings, reached
maximum levels at 12 h and declined again at 24 h.
Similarly, increased levels of the 85 kDa PARP cleavage
product were detectable at 4 to 8 h after exposure to UVB (Fig
6A), UVA1 (Fig 6B), and PUVA1 (Fig 6C), with highest activity
by 8 to 12 h and a decline thereafter.
In addition to the above described events of the apoptotic
signal transduction, two initial steps in this process, namely
changes in mitochondrial transmembrane potential and mito-
chondrial release of cytochrome C were analyzed as well.
Whereas the latter was found to increase up to 4-fold at 6 h
after irradiation with 75 mJ per cm2 from 12 ng cytosolic
cytochrome C per 106 cells in case of the untreated control, to
53.6 ng in UVB treated cells, no changes in mitochon-
drial transmembrane potential were noted under any of the
conditions studied (data not shown).
UV-INDUCED MAST CELL APOPTOSIS 839VOL. 121, NO. 4 OCTOBER 2003
Figure1. UV irradiation induces apoptosis of HMC-1 cells in a
time- and dose-dependent manner. HMC-1 cells were exposed to dif-
ferent doses of UVB (A), UVA1 (B), and PUVA1 (C), incubated for 0 to 48
h, and apoptosis assessed by £ow cytometric analysis of cell membrane in-
tegrity. Data represent the mean7SEM of four to seven experiments.
Figure 2. Increasing number of dead HMC-1 cells as a postapoptotic
event after UV irradiation. HMC-1 cells were exposed to di¡erent doses
of UVB (A), UVA1 (B), and PUVA1 (C), incubated for 0 to 48 h, and cell
death assessed by FACS analysis. Data represent the mean7SEM of four to
seven experiments.
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Primary skin mast cells fail to undergo apoptosis in
response to UV irradiation In order to investigate the e¡ect
of UV irradiation on survival of primary mast cells, puri¢ed
skin mast cells were irradiated with UVB (75 and 100 mJ per
cm2), UVA1 (15 J per cm2), and PUVA1 (5 J per cm2) and the
number of apoptotic, dead and viable cells was quanti¢ed after
24, 48, and 72 h postradiation by Vybrant Apoptosis Assay. In
contrast to the immature, strongly proliferating HMC-1 cell
line, cutaneous mast cells failed to undergo apoptosis in response
to UV light (Table II). Even the usage of a single high UVB
dosage of 200 or 500 mJ per cm2 did not cause a signi¢cant
apoptotic e¡ect. To evaluate whether repeated low-dose UV
irradiation, as usually used in vivo for the treatment of mast
cell-associated cutaneous diseases, would a¡ect the survival of
Figure 3. Ultrastructure of HMC-1 cells undergoing apoptosis after
treatment with UV irradiation. (A) Untreated control HMC-1 cells ex-
hibit a normal morphology with an intact nucleus and regularly distribu-
ted chromatin. (B) After irradiation with 75 mJ per cm2 UVB and
subsequent incubation for 12 h, HMC-1 cells show morphologic features
typical of apoptosis such as the formation of apoptotic bodies containing
chromatin fragments (arrow 1) and excessive membrane blebbing (arrow 2)
(original magni¢cation  6000).
Figure 4. UV irradiation activates caspase-3 in HMC-1 cells in a
time- and dose-dependent manner. HMC-1 cells were treated with dif-
ferent doses of UVB (A), UVA1 (B), and PUVA1 (C) irradiation, incubated
for 0 to 48 h, and activity of caspase-3 assessed by £uorimetric measure-
ment of DEVD-AMC cleavage. Data represent the mean of three represen-
tative independent experiments UVB and single experiments for UVA1
and PUVA1.
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skin mast cells, we next irradiated cutaneous mast cells for 2 wk
with 5 mJ per cm2 UVB three times weekly; however, repeated
low-dose UVB irradiation (5 mJ per cm2) over 2 wk also failed to
a¡ect survival of cutaneous mast cells kept in culture conditions
with low-dose SCF and IL-4 (data not shown).
Responsiveness of primary cells and related cell lines to di¡erent
apoptotic stimuli, as shown by caspase 3 activation In order to
examine if mature dermal mast cells are completely resistant to
apoptosis (either to UV light induced or other damaging agents)
additional experiment with UVB, staurosporine, and cycloheximide
were performed. Furthermore, mast cells (and proliferating mature
mast cells) were compared with freshly isolated keratinocytes,
representing a di¡erent type of a skin resident cell and HaCaT as an
example for the strongly proliferating keratinocytes. The cell line
KU812 was additionally chosen, as it bears characteristics of mast
cells (and basophils), but unlike HMC-1 lacks the mutation in the c-
Kit gene.
As shown in Fig 7 resting dermal mast cells poorly respond to all
stimuli applied. Only staurosporine was able to exert a marginal
caspase-3 activation. In contrast the HMC-1 and KU812 were highly
sensitive to apoptotic stimuli. In an additional experiment with
proliferating dermal mast cells the sensitivity of mast cells to all
stimuli was elevated, indicating that mature mast cells are still able to
undergo apoptosis under certain conditions. Interestingly UVB
turned out to be most potent. Similar to mast cells, freshly isolated
keratinocytes were moderately receptive to UVB-induced apoptosis
(marked e¡ects were visible after cycloheximide treatment), whereas
highly proliferating HaCaT showed pronounced apoptotic responses
especially to UVB.
DISCUSSION
The present data demonstrate for the ¢rst time that human mast
cells can be induced to undergo classical apoptotic changes in
Figure 5. UV irradiation elevates p53 protein levels in nuclear ex-
tracts of HMC-1 cells. After treatment of HMC-1 cells with UV irradia-
tion and subsequent incubation for 0 to 24 h, nuclear protein was extracted
and immunoblotting performed with anti-p53 antibody. (A) Lanes 1^5,
unirradiated sham controls after an incubation of 0, 4, 8, 12, and 24 h; lanes
6 to 10, cells irradiated with 75 mJ per cm2 UVB after an incubation of 0, 4,
8, 12, and 24 h; (B) lanes 1 to 5, unirradiated sham controls after an incuba-
tion of 4, 8, 12, and 24 h; lanes 6 to 10, cells irradiated with 20 J per cm2
UVA1 after an incubation of 0, 4, 8, 12, and 24 h; (C) lanes 1 to 5, unirra-
diated sham controls pretreated with 8-MOP after an incubation of 0, 4, 8,
12, and 24 h; lanes 6 to 10, cells irradiated with 5 J per cm2 PUVA1 after an
incubation of 0, 4, 8, 12, and 24 h. Data are representative of three indepen-
dent experiments with similar results.
Figure 6. UV irradiation leads to an enhanced cleavage of PARP in
nuclear extracts of HMC-1 cells. After treatment of HMC-1 cells with
UV irradiation and subsequent incubation for 0 to 24 h, nuclear protein
was extracted and immunoblotting performed with anti-PARP antibody.
(A) Lanes 1 to 5, unirradiated sham controls after an incubation of 0, 4, 8,
12, and 24 h; lanes 6 to 10, cells irradiated with 75 mJ per cm2 UVB after
an incubation of 0, 4, 8, 12, and 24 h; (B) lanes 1 to 5, unirradiated sham
controls after an incubation of 4, 8, 12, and 24 h; lanes 6 to 10, cells irradiated
with 20 J per cm2 UVA1 after an incubation of 0, 4, 8, 12, and 24 h; (C) lanes
1 to 5, unirradiated sham controls pretreated with 8-MOP after an incuba-
tion of 0, 4, 8, 12, and 24 h; lanes 6 to 10, cells irradiated with 5 J per cm2
PUVA1 after an incubation of 0, 4, 8, 12, and 24 h. Data from two experi-
ments with similar results.
Figure 7. Caspase-3 activation in di¡erent cell types in response to
UVB, staurosporine, and cycloheximide. Mature dermal mast cells
(Mc) poorly respond to any apoptotic stimuli applied. Only staurosporine
is su⁄cient to activate caspase-3 in a moderate fashion (n¼ 9, pp0.05). In
contrast in mature but proliferating dermal mast cells (cultured with
SCF7IL-4 for 2 wk) especially UVB was able to induce of caspase-3 acti-
vation (single experiment). The proliferating cell lines HMC-1 and KU 812
are highly sensitive to UV light and staurosporine (n¼ 3, pp0.05), but less
to cycloheximide treatment. Similar to mast cells, freshly isolated keratino-
cytes (n¼ 6, pp0.05) moderately react on UVB, but on the other side
they are sensitive to cycloheximide. HaCaT cells were more sensitive to
UVB as compared with primary keratinocytes, but poorly respond to
staurosporine.
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response to irradiation with UVB or UVA1 as shown in the hu-
man immature mast cell line HMC-1. Dose-dependency of the
apoptotic response could be shown using di¡erent treatment
regimens. E¡ects were more pronounced with UVB, although
similar results were obtained with very low doses of UVA1 when
cells had been presensitized with psoralens. The morphologic fea-
tures and the associated biochemical events during apoptosis of
HMC-1 cells seem similar to those in other cell types except for
depolarization of the transmembrane potential which, however,
does not seem to constitute an essential feature of apoptosis as
shown in HeLa cells (Bossy-Wetzel et al, 1998).
Activation of the tumor suppressor gene p53 has been shown
to participate in UV-induced apoptosis of other cell types (Evan
and Littlewood, 1998; Godar, 1999a). Interestingly the activation
of p53 seems not to be essential in every case of UVA-induced
apoptosis as shown in keratinocytes, where p53 is only activated
after UVB exposure but not after UVA exposure (Wang et al,
1998). p53 independent (Gniadecki et al, 1997), and oxidative
stress-related pathways have been described (Godar, 1999b). Our
data demonstrate that UV-induced apoptosis of mast cells clearly
includes activation of p53.Various studies, however, indicate that
this molecule indeed is a key player in the cellular response to
UV irradiation. In order to control the UV-induced DNA da-
mage and to maintain the genomic stability, a sequence of bio-
chemical events are initiated that either repair the DNA damage
or induce apoptosis. Most likely, p53 is involved in both DNA
repair as well as apoptosis (Kastan et al, 1991; Zhan et al, 1993; Li
and Ho, 1998).To allow for e⁄cient repair of the DNA prior to its
transfer to daughter cells, p53 ¢rst induces cell cycle arrest in the
G1 phase. In addition, p53 then directly participates in DNA re-
pair by attracting and regulating speci¢c repair proteins, e.g.,
P53R2 (Tanaka et al, 2000; Nakano et al, 2000). In cells with irre-
parable DNA damage, such as after prolonged UVexposure or g-
irradiation, p53 promotes apoptosis by activating proapoptotic
molecules such as bax (Miyashita and Reed, 1995), PIDD (Lin et
al, 2000), Noxa (Oda et al, 2000a), or P53AIP1 (Oda et al, 2000b).
In accordance, studies on ¢broblasts have demonstrated that
low-dose UV irradiation preferentially triggers DNA repair,
whereas high-dose UV irradiation induces apoptosis in the same
cell type, and both mechanisms have been shown to depend on
activation of p53 (Li and Ho, 1998). The ¢ndings in this study de-
monstrate that apoptosis of HMC-1 cells induced by UV treat-
ment is also quantitatively linked to the expression of p53 (Fig 5).
A pronounced induction of p53 was observed in HMC-1 cells
treated with the combination of the photosensitizer 8-MOP and
UVA1 (Fig 5C), whereas less markedly increased p53 levels were
seen after exposure to UVA1 alone (Fig 5B) or UVB (Fig 5A).
The inability to induce apoptosis by UV light in normal skin
mast cells, even with high single dose UVB and after repetitive
low-dose UVB irradiation, is a very interesting aspect of this study
because of its potential implications. The failure to induce apoptosis
in mature mast cells is in line with previous ¢ndings showing that
normal tissue mast cells are long lived cells hardly proliferating and
have in fact been found to persist for a life time in rats (Kiernan,
1979). Further indications pointing at the proliferation rate is given
by our data that skin mast cells cultured with high levels of SCF and
IL-4, which induces proliferation, were indeed susceptible to UV
light. This correlates with the ¢ndings from experiments performed
with cultured murine bone marrow-derived mast cells that have
attained a high level of maturity during culture were also highly re-
sistant to induction of apoptosis with anti-CD95, whereas immature
murine mast cells responded, however readily, in the same study
(Hartmann et al, 1997). Thus one must assume an increased sensitiv-
ity to apoptotic signals in immature mast cells.The leukemic HMC-
1 cells have been characterized as morphologically and functionally
immature mast cells (Butter¢eld et al, 1988; Hamann et al, 1994),
which have a functional mutation of the SCF receptor (Furitsu et
al, 1993). The same activating mutation is also seen in mast cells in
cutaneous mastocytosis (urticaria pigmentosa) in adults (Algermis-
sen et al, 1994; Haas et al, 1994; Bˇttner et al, 1998). As the KU812 cells
that lack the mutation in the c-Kit gene were even more prone to
UV light induced apoptosis than any other cells tested in this study,
however, the susceptibility of HMC-1 cells to UV light (in compar-
ison with mature mast cells) seems thus more likely related to a high
proliferation activity and immaturity than to the mutation in c-Kit.
This is mirrored by our ¢ndings that keratinocytes exhibit also
higher rates of UV-induced apoptosis in the strongly proliferating
HaCaT than in primary keratinocytes, which is in line with the ob-
servations from Petit-Frere et al (2000b), who compared the e¡ect of
UV light from the spontaneously immortalized HaCaT cell line to
freshly isolated keratinocytes towards UVB. From a biologic point
of view the di¡erentiated resting mast cells found mainly in the
upper dermis share their resistance to UV light-induced apoptosis
with melanocytes that are also exposed to constant UV bombard-
ment due to their natural location in the skin. High anti-oxidative
activity has been proposed as a protective mechanism against mito-
chondrial damage in melanocytes (Salvucci et al, 2001) and similar
processes are known to be operative in mast cells (Brooks et al,
1999). Recently, key molecules involved in or associated with FceRI
signaling, phosphoinositol-3-kinase and Akt are discussed as nega-
tive modulators of apoptosis and may therefore be also of impor-
tance in regulating mast cell apoptosis (Webb et al, 2000; Zhou
et al, 2000). In this context the role of monomeric IgE on apoptosis
and survival of mast cells is reviewed by Kawakami and Galli, 2002).
In conclusion our data suggest that the apoptotic reactivity of mast
cells is related to proliferation and maturation. In healthy skin, the
resistance of resting cutaneous mast cells to apoptosis ensures long-
term survival of these cells and thus their continuous functional
integrity in natural and acquired immune defense (Henz et al,
2001) despite constant exposure to potentially damaging UV
light. On the other hand, UV light is an e¡ective treatment in con-
trolling mast cell number in conditions, where proliferating mast
cells accumulate in the skin, in the context of in£ammation or mas-
tocytosis.
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